Incretin-based investigational therapies for the treatment of MASLD/MASH US$ 20.46 Min. order: 1 piece ★★★★★ 4.0 (192 reviews) Sold : Login>>
GLP-1 single, dual, and triple receptor agonists for treating type 2 diabetes and obesity: a narrative review US$ 20.75 Min. order: 1 piece ★★★★★ 4.0 (32 reviews) Sold : Login>>
PDF] Once-weekly cagrilintide for weight management in people with overweight and obesity: a multicentre, randomised, double-blind, placebo-controlled and active-controlled, dose-finding phase 2 trial US$ 23.22 Min. order: 1 piece ★★★★★ 4.0 (146 reviews) Sold : Login>>